AltaRex Corp. (Waltham, MA) reports...

AltaRex Corp. (Waltham, MA) reports favorable early deductions from its Phase 2 clinical trial of OvaRex/second-line chemotherapy in relapsed ovarian cancer patients for whom the prognosis is extraordinarily poor, and for whom salvage chemotherapy alone provides limited clinical benefit. Following administration of OvaRex MAb, immune responses--both robust humoral (71% of the

Calling Cards , Buy Stomp The Yard Movie Dvd , Iran Phone Cards , Car Tuning , Medicine Rogue Gene Science